EODData

FRA, C5G: Orexo AB (publ)

22 Jan 2026
LAST:

2.810

CHANGE:
 0.01
OPEN:
2.810
HIGH:
2.810
ASK:
0.000
VOLUME:
300
CHG(%):
0.36
PREV:
2.800
LOW:
2.810
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Jan 262.8102.8102.8102.810300
21 Jan 262.8002.8002.8002.800300
20 Jan 262.7302.7302.7302.730300
19 Jan 262.8452.8452.8452.845300
16 Jan 262.9652.9652.9652.965300
15 Jan 262.9452.9452.9452.945300
14 Jan 263.0753.0753.0753.075300
13 Jan 263.1653.1653.1653.165300
12 Jan 263.1703.1703.1703.170300
09 Jan 263.2403.2403.2403.240300

PROFILE

Name:Orexo AB (publ)
About:Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Sector:Healthcare
Address:Rapsgatan 7E, Uppsala, Sweden
Website:https://www.orexo.com
ISIN:SE0000736415
LEI:549300LJ5CCWDPTK9Z08

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.43 
Forward P/E:9.75 
PEG Ratio:-0.04 
Price to Sales:1.69 
Price to Book:-0.44 
Profit Margin:-0.37 
Operating Margin:-0.22 
Return on Assets:-0.16 
Return on Equity:1.61 
Revenue:54.62M 
EBITDA:5.42M 
Shares:34.51M 
Market Cap:96.96M 

TECHNICAL INDICATORS

MA5:2.830.7%
MA10:2.975.9%
MA20:2.892.9%
MA50:2.589.1%
MA100:2.5310.9%
MA200:2.0238.9%
STO9:18.18 
STO14:12.40 
RSI14:52.82
WPR14:-87.60 
MTM14:-0.57
ROC14:-0.17 
ATR:0.11 
Week High:2.975.5%
Week Low:2.732.9%
Month High:3.3820.1%
Month Low:2.1238.9%
Year High:3.8336.1%
Year Low:1.09158.0%
Volatility:23.95